Literature DB >> 24426756

Designing liver resections and pushing the envelope with resections for hepatic colorectal metastases.

Mary L Guye1, Hans F Schoellhammer1, Louisa W Chiu1, Joseph Kim1, Lily L Lai1, Gagandeep Singh1.   

Abstract

Current concepts in the management of hepatic metastases have changed dramatically over the past two decades. Multidisciplinary therapies including chemotherapy, surgery, and regional therapy have alone and in combination significantly improved the survival of patients with metastatic colorectal cancer. Conditions that were previously considered hopeless and treated merely for palliation can now be approached with curative intent. In this paper, we review the surgical treatment for colorectal cancer liver metastasis (CRLM) and describe a paradigm-shift in the management of complex heretofore-considered unresectable CRLM. Utilizing advanced multidisciplinary treatment strategies has improved the prognosis of patients with stage IV colorectal cancer to the point where we may question whether CRLM are now a chronic disease.

Entities:  

Keywords:  Colorectal cancer (CRC); hepatectomy; liver resection; metastasectomy; metastatic colorectal cancer (mCRC); surgical management, survival

Year:  2013        PMID: 24426756      PMCID: PMC3890025          DOI: 10.1007/s13193-013-0256-5

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN: 0975-7651


  71 in total

1.  Selection of patients for resection of hepatic colorectal metastases: expert consensus statement.

Authors:  Chusilp Charnsangavej; Bryan Clary; Yuman Fong; Axel Grothey; Timothy M Pawlik; Michael A Choti
Journal:  Ann Surg Oncol       Date:  2006-09-01       Impact factor: 5.344

2.  Benefits and risks of neoadjuvant therapy for liver metastases.

Authors:  Bernard Nordlinger; Stéphane Benoist
Journal:  J Clin Oncol       Date:  2006-11-01       Impact factor: 44.544

3.  What defines 'cure' after liver resection for colorectal metastases? Results after 10 years of follow-up.

Authors:  Carlo Pulitanò; Federico Castillo; Luca Aldrighetti; Martin Bodingbauer; Rowan W Parks; Gianfranco Ferla; Stephen J Wigmore; O James Garden
Journal:  HPB (Oxford)       Date:  2010-05       Impact factor: 3.647

Review 4.  Liver resection for metastatic colorectal cancer in the age of neoadjuvant chemotherapy and bevacizumab.

Authors:  Peter S Yoo; Reynold I Lopez-Soler; Walter E Longo; Charles H Cha
Journal:  Clin Colorectal Cancer       Date:  2006-09       Impact factor: 4.481

Review 5.  Cancer treatment and survivorship statistics, 2012.

Authors:  Rebecca Siegel; Carol DeSantis; Katherine Virgo; Kevin Stein; Angela Mariotto; Tenbroeck Smith; Dexter Cooper; Ted Gansler; Catherine Lerro; Stacey Fedewa; Chunchieh Lin; Corinne Leach; Rachel Spillers Cannady; Hyunsoon Cho; Steve Scoppa; Mark Hachey; Rebecca Kirch; Ahmedin Jemal; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2012-06-14       Impact factor: 508.702

6.  Liver resection for colorectal metastases.

Authors:  Y Fong; A M Cohen; J G Fortner; W E Enker; A D Turnbull; D G Coit; A M Marrero; M Prasad; L H Blumgart; M F Brennan
Journal:  J Clin Oncol       Date:  1997-03       Impact factor: 44.544

7.  Microwave ablation of liver metastases guided by contrast-enhanced ultrasound: experience with 125 metastases in 39 patients.

Authors:  T Lorentzen; B O Skjoldbye; C P Nolsoe
Journal:  Ultraschall Med       Date:  2011-01-21       Impact factor: 6.548

Review 8.  Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases.

Authors:  D Zorzi; A Laurent; T M Pawlik; G Y Lauwers; J-N Vauthey; E K Abdalla
Journal:  Br J Surg       Date:  2007-03       Impact factor: 6.939

9.  Actual 10-year survival after resection of colorectal liver metastases defines cure.

Authors:  James S Tomlinson; William R Jarnagin; Ronald P DeMatteo; Yuman Fong; Peter Kornprat; Mithat Gonen; Nancy Kemeny; Murray F Brennan; Leslie H Blumgart; Michael D'Angelica
Journal:  J Clin Oncol       Date:  2007-10-10       Impact factor: 44.544

10.  Surgical treatment of hepatic and pulmonary metastases from colorectal cancers.

Authors:  J F Regnard; D Grunenwald; L Spaggiari; P Girard; D Elias; M Ducreux; P Baldeyrou; P Levasseur
Journal:  Ann Thorac Surg       Date:  1998-07       Impact factor: 4.330

View more
  2 in total

1.  CircFADS2: A potential prognostic biomarker of colorectal cancer.

Authors:  Yi-Sheng Xiao; Hua-Zhang Tong; Xi-Hong Yuan; Chang-Hui Xiong; Xiao-Yang Xu; Yuan-Feng Zeng
Journal:  Exp Biol Med (Maywood)       Date:  2020-06-02

Review 2.  [Computed tomography and/or magnetic resonance imaging of the liver : How, why, what for?]

Authors:  G H Pöhler; K I Ringe
Journal:  Radiologe       Date:  2019-09       Impact factor: 0.635

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.